Hematologist
CION Cancer Clinics
Childhood AML and how its treatment differs | CION Cancer Clinics
Childhood AML is usually treated with a few courses of strong chemotherapy, given in hospital over roughly six months. That is shorter than treatment for ALL, but far more intense, with long hospital stays while blood counts recover and usually no maintenance phase at home. Some types, such as APL, follow a different plan. This page explains the pathway, the report words and the questions to ask. At CION Cancer Clinics, our haematology team supports patients and families through treatment, cost questions and life at home.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- How is AML treated in children, and how is it different from ALL?
- What changes when it is AML instead of ALL?
- What happens from diagnosis to the end of treatment?
- Which kinds of childhood AML are treated differently?
- Why does my child need to stay in hospital so long?
- What do families often believe about childhood AML?
- What do the words on an AML report mean?
- Common questions about childhood AML treatment
The short answer
How is AML treated in children, and how is it different from ALL?
Childhood acute myeloid leukaemia (AML) is usually treated with a few courses of strong chemotherapy given in hospital over roughly six months. Compared with ALL, the treatment is shorter but much more intense, and there is usually no long maintenance phase at home.
Two different leukaemias
Both start in the bone marrow, the soft tissue inside bones where blood is made. ALL grows from cells that would become lymphocytes, a type of white cell. AML grows from cells that would become other white cells, red cells or platelets. The two respond to different medicines, so a child with AML does not follow the ALL plan.
Why the intensity matters to your family
Each course pushes the blood counts very low for weeks. Most children stay in hospital, or very close to it, for much of that time, because infections can become serious quickly. For parents this usually means long stretches away from home, work and other children. Planning for that early helps.
Who this pattern does not fit
A few types of AML are treated quite differently, and the next sections explain them. Your child's plan depends on tests on the leukaemia cells, so it may not match what you read here.
Side by side
What changes when it is AML instead of ALL?
Childhood ALL
Childhood AML
The more common leukaemia in children
Much less common in children
Treatment usually runs for around two years or more
Treatment is usually over in months
Long maintenance with tablets at home
Usually no maintenance phase
Many weeks are spent at home between visits
Long hospital stays after each course are common
Stem cell transplant is used only in some cases
Transplant is discussed more often, for higher-risk types
Not sure whether this applies to you?
Ask an oncologistThe pathway
What happens from diagnosis to the end of treatment?
-
Tests on the marrow
A bone marrow test confirms AML and looks at the genes and chromosomes inside the leukaemia cells. These results decide the risk group and shape the whole plan, so they are worth waiting for.
-
The first course (induction)
Chemotherapy is given into a central line over several days. The aim is remission, meaning leukaemia can no longer be seen in the marrow. Your child then stays under close watch while counts recover.
-
Checking the response
Another marrow test shows how well the first course worked, often including an MRD test for tiny amounts of leukaemia left behind.
-
Further courses
More courses follow, each with its own hospital stay and recovery. These keep the leukaemia from growing back.
-
The transplant decision
For some higher-risk children, the team discusses a stem cell transplant. Many children do not need one.
-
Follow-up
Regular visits continue for years, with blood tests and checks for late effects of treatment.
Not every AML is the same
Which kinds of childhood AML are treated differently?
The name on the report matters. These groups follow their own plans, and your child's haematologist will tell you if one applies.
Acute promyelocytic leukaemia (APL)
A subtype that can cause dangerous bleeding early on. It is often treated with medicines called ATRA and arsenic trioxide, with less chemotherapy. Starting treatment quickly matters.
AML in children with Down syndrome
Leukaemia in young children with Down syndrome often responds to gentler chemotherapy. These children can also be more sensitive to side effects, so the doses are planned differently.
AML with certain gene changes
Some leukaemias carry changes that point to a targeted medicine alongside chemotherapy, or to a transplant.
You may see on the report
- FLT3 changes
- KMT2A rearrangement
- Monosomy 7
AML that returns
If AML comes back, the plan changes. It may include different chemotherapy, a clinical trial or a transplant. The team will explain the options and what each involves.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
During treatment
Why does my child need to stay in hospital so long?
Because the counts fall so low after each course, a simple infection can turn serious within hours. Staying in or near the hospital means fever is treated at once, with antibiotics through the line.
Support your child will need
Blood and platelet transfusions are common while the marrow recovers. Mouth sores, poor appetite and sickness can make eating hard, and some children need feeding support for a while. None of this means treatment is failing. It is the expected cost of strong chemotherapy.
How CION fits in
CION's haematology team, led by Dr. Basudev Pokhrel, reviews the reports, presents the case at a tumour board and coordinates care with qualified paediatric centres for intensive courses and transplant. CION does not perform stem cell transplants itself. Ask any centre how many children with AML it treats, who covers nights and how fever is handled.
What this page cannot tell you
It cannot tell you your child's risk group or outlook. Those depend on the gene results and how the leukaemia responds. Ask your haematologist to explain your own child's picture.
Commonly believed
What do families often believe about childhood AML?
"Shorter treatment means AML is the milder leukaemia."
Shorter does not mean easier. Each AML course is harder on the body than most ALL treatment. The plan is short because of how AML responds, not because it is less serious.
"We can start treatment back home and come later."
AML moves fast, and the first weeks carry real risks, including bleeding and infection. Treatment should start at a centre equipped for intensive children's blood cancer care, without delay.
"Every child with AML needs a transplant."
Many children finish treatment with chemotherapy alone. Transplant is considered for higher-risk types or AML that returns, after the team weighs the benefits against its own risks.
"Something we did caused this."
In almost all children, nothing the family did or failed to do caused AML. It is not caught from anyone and it is not a punishment. Guilt is common, and it is worth talking about.
On the report
What do the words on an AML report mean?
- Blasts
- Young, immature blood cells. In AML the marrow fills with them, and the team counts them to judge the response.
- Cytogenetics
- Tests on the chromosomes of the leukaemia cells. The results help set the risk group.
- Remission
- Leukaemia can no longer be seen in the marrow under the microscope. Treatment still continues after this.
- MRD (minimal residual disease)
- A very sensitive test for tiny amounts of leukaemia left after a course.
- Central line
- A thin tube placed into a large vein in the chest, so medicines and blood tests do not need repeated needles.
Questions parents ask
Common questions about childhood AML treatment
How long does treatment for childhood AML take?
For most children the main treatment is a few courses of chemotherapy spread over roughly six months, including the recovery time in between. Types such as APL, or a child who needs a transplant, follow a different timeline. Ask the team for a written outline of your child's courses.
Will my child be in hospital the whole time?
Much of it, but not all. Children often stay in until the counts recover after each course, and some go home for a short break before the next one. Families from districts may be asked to stay close to the centre, so a fever can be treated quickly.
Can my child go to school during AML treatment?
Usually not during the intensive courses, because the risk of infection is high. Many hospitals have teachers or play staff, and schools can send work home. Most children return to school some months after treatment ends, once the team agrees counts and energy allow it.
Does my child need a stem cell transplant?
Not always. It depends on the gene results and how the leukaemia responds to the first courses. If a transplant is suggested, ask why, what the other options are, who the donor might be, and which centre would do it. CION coordinates referral to qualified transplant centres.
Should brothers and sisters be tested as donors?
Only if the team suggests a transplant may be needed. A matching brother or sister is often the first donor looked for. Testing is a simple sample, but the result carries a lot of emotion for a sibling, so prepare them gently and involve them in what it means.
Why does my child need so many blood transfusions?
Chemotherapy stops the marrow making enough red cells and platelets for a while. Transfusions keep your child safe until the marrow recovers. The team decides when one is needed from blood tests and how your child is. Donating blood through the hospital's bank helps other families too.
Is childhood AML treatment covered by schemes?
Often, at least in part. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover chemotherapy and some hospital stays, but coverage for transplant and certain medicines varies. Scheme rules change, so check the current entitlements with the centre's scheme desk before treatment starts.
What happens after treatment ends?
Regular follow-up visits begin, first often and then less often. Blood tests look for any sign of the leukaemia returning, and later checks cover the heart, growth, hearing, learning and fertility. Tell the team early about fever, bruising or tiredness that does not settle.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer.Net — Leukemia - Acute Myeloid - AML - Childhood
- National Cancer Institute — Childhood Acute Myeloid Leukemia Treatment (PDQ) - Patient Version
- American Cancer Society — Leukemia in Children
- NHS — Acute myeloid leukaemia
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
MRD in Childhood LeukaemiaWhat the response test after each course meansPort and Central Line Care in a ChildLooking after the line through long hospital staysRelapsed Childhood LeukaemiaWhat changes if the leukaemia comes backChildhood Blood Cancer Treatment Cost in IndiaIndicative costs and which schemes may helpPaediatric Blood CancersEvery guide for families facing a child's blood cancer
Talk to us
Your child has just been diagnosed with AML?
Share the reports you have so far. CION's haematology team will review them, explain the plan and help you reach the right centre for each stage.